Lably
Skip to content

Bazedoxifene/conjugated estrogens

Combination drug

  • 1 min read
  • 1 chapters

Explore on Lably

ToursExplore Lably’s 3D tours

The combination was approved for medical use in the United States in October 2013, and in the European Union in December 2014.

More in Health

Food and Drug AdministrationFederal agency of the United States Department of Health and Human ServicesCenters for Disease Control and PreventionUnited States government public health agencyNauseaMedical symptom or conditionSeizurePeriod of symptoms due to excessive or synchronous neuronal brain activityVomitingExpulsion of stomach contents via the mouth or noseIntravenous therapyMedication administered into a vein